What's behind Clorox's latest 2.9% stock surge?

Traders Union
All News
Stocks
Clorox rises 2.9% to $87.34 today

Highlights

MAC Alpha Capital Management LP increased its position in Clorox by 88.7% in the second quarter, reaching over 263,000 shares.
Clorox management confirmed an elevated dividend yield as sales decline and debt near $4 billion strain free cash flow and dividend sustainability.
Shares of Clorox trade below key moving averages with ongoing bearish pressure and an expected five-day range of $85.08 to $89.61.

Dividend sustainability in focus amid fund accumulation and sector pressures

MAC Alpha Capital Management LP increased its position in Clorox by 88.7% during the second quarter, as shown in a recent SEC filing, bringing its holding to over 263,000 shares. Management recently acknowledged that the dividend yield is currently elevated, while analysis has pointed to sales declines and rising debt nearing $4 billion having put pressure on free cash flow and the sustainability of the dividend payout. Broader sector headwinds and the company’s financial metrics have also been highlighted as weighing on recent performance.

Anton Kharitonov, expert at Traders Union, sees ongoing technical weakness in Clorox. He notes the stock is persistently trading below all key moving averages, confirming a bearish long-term trend. Recent buying from MAC Alpha Capital Management failed to shift overall sentiment, with oversold technicals simply reflecting extended selling. Rising debt and shrinking free cash flow raise fundamental red flags, placing the dividend at risk. "Despite the rebound, I view the upside as limited and expect further declines unless critical resistance levels are reclaimed," says Kharitonov.

Viktoras Karapetjanc, expert at Traders Union, remains constructive about Clorox’s medium-term prospects. He points to strong institutional interest from MAC Alpha Capital Management as a sign of emerging confidence. While near-term volatility could persist, the elevated dividend yield and potential for a sales turnaround offer attractive entry for patient investors. Karapetjanc believes the market offers multiple setups for those willing to look past current headwinds. "I see renewed opportunity if momentum builds and the price breaks above resistance," he says.

Sholanke Dele, market strategist, remains cautious on Clorox’s outlook. She observes that news of increased institutional holdings has not resolved pressure from weak sales and rising debt. Short-term indicators point to persistent seller domination despite a temporary intraday rebound. "Investors should remain vigilant — the downside risks for Clorox still outweigh recovery hopes," warns Dele.

Bearish momentum persists as oversold signals face intraday strength

Clorox is trading below its 20-, 50-, and 200-day moving averages ($93.45, $98.06, and $102.31), signaling ongoing pressure from sellers across all timeframes and reinforcing a bearish longer-term trend. The nearest resistance is at $87.63 (today high), with a floor at $87.04 (week high). Distant overhead levels and the Ichimoku Kijun at $95.92 confirm the prevailing bearish structure but remain far above the current price. On momentum, both the MACD and Average Directional Index (ADX) indicate continued downside, consistent with readings from the Relative Strength Index (RSI, 28.11) and Commodity Channel Index (CCI, -98), both flagging oversold conditions. Stochastic RSI at 58.02 is flashing a "Strong Buy" signal. Bull/Bear Power (BBP) registers -3.36, showing sellers dominating intraday momentum and an "Oversold" reading. The Awesome Oscillator is negative and aligns with the prevailing bearish tone. Price is near the day's high, and intraday volatility stands at 1.19%. Intraday action is firm with strength toward highs, but the divergence in oversold and momentum signals underscores mixed near-term sentiment.

Earlier, analysts noted that Clorox remained under sustained selling pressure with technical indicators pointing to a dominant bearish trend. The current price rebound following increased institutional interest adds a new dimension but does not materially alter the prevailing downside risk, with $85.08 as a key level to watch for potential further declines.

Source of Data: CLX Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.